EGFR

You have access
Paclitaxel Impedes EGFR-mutated PC9 Cell Growth via Reactive Oxygen Species-mediated DNA Damage and EGFR/PI3K/AKT/mTOR Signaling Pathway Suppression
MD MOHIUDDIN and KAZUO KASAHARA

Cancer Genomics & Proteomics September 2021, 18 (5) 645-659; DOI: https://doi.org/10.21873/cgp.20287
Open Access
Expression of Pregnancy Up-regulated Non-ubiquitous Calmodulin Kinase (PNCK) in Hepatocellular Carcinoma
YOON AH CHO, SANGJOON CHOI, SUJIN PARK, CHEOL-KEUN PARK and SANG YUN HA

Cancer Genomics & Proteomics November 2020, 17 (6) 747-755; DOI: https://doi.org/10.21873/cgp.20229
Open Access
Influence of Concurrent Mutations on Overall Survival in EGFR-mutated Non-small Cell Lung Cancer
MATHIEU CHEVALLIER, PETROS TSANTOULIS, ALFREDO ADDEO and ALEX FRIEDLAENDER

Cancer Genomics & Proteomics September 2020, 17 (5) 597-603; DOI: https://doi.org/10.21873/cgp.20216
Open Access
Genotyping KRAS and EGFR Mutations in Greek Patients With Non-small-cell Lung Cancer: Incidence, Significance and Implications for Treatment
HELENA LINARDOU, VASSILIKI KOTOULA, GEORGE KOUVATSEAS, GIANNIS MOUNTZIOS, VASILIOS KARAVASILIS, EPAMINONDAS SAMANTAS, ANNA KALOGERA-FOUNTZILA, DESPINA TELEVANTOU, KYRIAKI PAPADOPOULOU, XANTHIPI MAVROPOULOU, EMILY DASKALAKI, THOMAS ZARAMBOUKAS, IOANNIS EFSTRATIOU, SOFIA LAMPAKI, GRIGORIOS RALLIS, ELENI RES, KONSTANTINOS N. SYRIGOS, PARIS A. KOSMIDIS, DIMITRIOS PECTASIDES and GEORGE FOUNTZILAS

Cancer Genomics & Proteomics November 2019, 16 (6) 531-541; DOI: https://doi.org/10.21873/cgp.20155
Open Access
Gene Expression Comparison Between the Primary Tumor and its Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma: A Pilot Study
GEORGIA KARPATHIOU, MARIE-LAURIE STACHOWITZ, JEAN MARC DUMOLLARD, MARIE GAVID, MARIOS FROUDARAKIS, JEAN MICHEL PRADES and MICHEL PEOC'H

Cancer Genomics & Proteomics May 2019, 16 (3) 155-161; DOI: https://doi.org/10.21873/cgp.20121
Open Access
EGFR L861Q Mutation in a Metastatic Solid-pseudopapillary Neoplasm of the Pancreas
KEVIN G. NEILL, JAMES SALLER, SAMEER AL DIFFALHA, BARBARA A. CENTENO, MOKENGE P. MALAFA and DOMENICO COPPOLA

Cancer Genomics & Proteomics May 2018, 15 (3) 201-205;
Open Access
Prognostic Evaluation of Epidermal Growth Factor Receptor (EGFR) Genotype and Phenotype Parameters in Triple-negative Breast Cancers
SOFIA LEVVA, VASSILIKI KOTOULA, IOANNIS KOSTOPOULOS, KYRIAKI MANOUSOU, CHRISTOS PAPADIMITRIOU, KYRIAKI PAPADOPOULOU, SOTIRIS LAKIS, KYRIAKOS KOUKOULIAS, VASILIOS KARAVASILIS, GEORGE PENTHEROUDAKIS, EUFEMIA BALASSI, FLORA ZAGOURI, IOANNIS G. KAKLAMANOS, DIMITRIOS PECTASIDES, EVANGELIA RAZIS, GERASIMOS ARAVANTINOS, PAVLOS PAPAKOSTAS, DIMITRIOS BAFALOUKOS, GRIGORIOS RALLIS, HELEN GOGAS and GEORGE FOUNTZILAS

Cancer Genomics & Proteomics May 2017, 14 (3) 181-195;
Open Access
Epidermal Growth Factor Receptor (EGFR) and Keratin 5 (K5): Versatile Keyplayers Defining Prognostic and Therapeutic Sub-classes of Head and Neck Squamous Cell Carcinomas
ANCA MARIA CIMPEAN, RALUCA AMALIA BALICA, IOAN CAIUS DOROS, NICOLAE CONSTANTIN BALICA, PUSA NELA GAJE, RAMONA AMINA POPOVICI and MARIUS RAICA

Cancer Genomics & Proteomics January 2016, 13 (1) 75-81;
You have access
Preclinical Rationale for Combining an EGFR Antibody with Cisplatin/Gemcitabine for the Treatment of NSCLC
Selda Samakoglu, Dhanvanthri S. Deevi, Huiling Li, Su Wang, Mary Murphy, Channa Bao, Rajiv Bassi, Marie Prewett and James R. Tonra

Cancer Genomics & Proteomics March 2012, 9 (2) 77-92;

Main menu

User menu

Search

EGFR